Repare Therapeutics Investor Relations Material
Latest events
Investor Update
Repare Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Repare Therapeutics Inc
Access all reports
Repare Therapeutics Inc. (RPTX) is a clinical-stage precision oncology company focused on the development of novel therapeutics using its synthetic lethality approach. The company leverages its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop cancer therapies aimed at genomic instability, including DNA damage repair.
Key slides for Repare Therapeutics Inc
Corporate Presentation
Repare Therapeutics Inc
Corporate Presentation
Repare Therapeutics Inc
Latest articles
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
RPTX
Country
🇺🇸 United States